Belpointe Asset Management LLC Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Belpointe Asset Management LLC boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 26,662 shares of the company’s stock after acquiring an additional 1,927 shares during the period. Belpointe Asset Management LLC’s holdings in GE HealthCare Technologies were worth $2,261,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. CoreFirst Bank & Trust acquired a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $25,000. Runnymede Capital Advisors Inc. purchased a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $28,000. Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $32,000. OFI Invest Asset Management purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $34,000. Finally, Flagship Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $64.39 on Tuesday. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a market capitalization of $29.45 billion, a price-to-earnings ratio of 14.87, a PEG ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock’s fifty day moving average is $81.29 and its two-hundred day moving average is $83.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.22%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $97.73.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.